TherapeuticsMD Announces Third Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
TherapeuticsMD (TXMD) Tops Q3 EPS by 6c
November 6, 2019 4:52 PM ESTTherapeuticsMD (NASDAQ: TXMD) reported Q3 EPS of ($0.13), $0.06 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $23.72 million versus the consensus estimate of $8.14 million.
We are very pleased with our results for the quarter, which are in-line with our financial guidance, and reaffirm... More
